Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus P Halfon, M Bourlière, G Pénaranda, R Deydier, C Renou, ... Comparative hepatology 4, 1-7, 2005 | 222 | 2005 |
AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient-tailored approach J Seitz, C Bars, G Théodore, S Beurtheret, N Lellouche, M Bremondy, ... Journal of the American College of Cardiology 69 (3), 303-321, 2017 | 210 | 2017 |
Independent prospective multicenter validation of biochemical markers (fibrotest–actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis … P Halfon, M Bourliere, R Deydier, D Botta-Fridlund, C Renou, A Tran, ... Official journal of the American College of Gastroenterology| ACG 101 (3 …, 2006 | 204 | 2006 |
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies M Bourliere, G Penaranda, C Renou, D Botta‐Fridlund, A Tran, I Portal, ... Journal of viral hepatitis 13 (10), 659-670, 2006 | 180 | 2006 |
Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process X Adhoute, G Penaranda, S Naude, JL Raoul, H Perrier, O Bayle, ... Journal of hepatology 62 (4), 855-862, 2015 | 177 | 2015 |
Association of autofluorescence-based detection of the parathyroid glands during total thyroidectomy with postoperative hypocalcemia risk: results of the PARAFLUO multicenter … F Benmiloud, G Godiris-Petit, R Gras, JC Gillot, N Turrin, G Penaranda, ... JAMA surgery 155 (2), 106-112, 2020 | 166 | 2020 |
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C P Halfon, Y Bacq, A De Muret, G Penaranda, M Bourliere, D Ouzan, ... Journal of hepatology 46 (3), 395-402, 2007 | 165 | 2007 |
How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited J Lambert, P Halfon, G Penaranda, P Bedossa, P Cacoub, F Carrat Clinical Chemistry 54 (8), 1372-1378, 2008 | 144 | 2008 |
Impact of autofluorescence-based identification of parathyroids during total thyroidectomy on postoperative hypocalcemia: a before and after controlled study F Benmiloud, S Rebaudet, A Varoquaux, G Penaranda, M Bannier, ... Surgery 163 (1), 23-30, 2018 | 137 | 2018 |
A national survey of acute hepatitis E in France C Renou, X Moreau, A Pariente, JF CADRANEL, E Maringe, T Morin, ... Alimentary pharmacology & therapeutics 27 (11), 1086-1093, 2008 | 134 | 2008 |
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study–ANRS HC02 P Cacoub, F Carrat, P Bédossa, J Lambert, G Pénaranda, C Perronne, ... Journal of hepatology 48 (5), 765-773, 2008 | 121 | 2008 |
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection P Halfon, M Bourlière, G Pénaranda, H Khiri, D Ouzan Journal of clinical microbiology 44 (7), 2507-2511, 2006 | 111 | 2006 |
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status P Halfon, M Bourliere, S Pol, Y Benhamou, D Ouzan, M Rotily, H Khiri, ... Journal of viral hepatitis 13 (5), 329-335, 2006 | 100 | 2006 |
Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data V Leroy, P Halfon, Y Bacq, J Boursier, MC Rousselet, M Bourlière, ... Clinical biochemistry 41 (16-17), 1368-1376, 2008 | 97 | 2008 |
Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma A Laquière, C Boustière, S Leblanc, G Penaranda, E Désilets, F Prat Surgical endoscopy 30, 1242-1248, 2016 | 93 | 2016 |
Hepatitis E virus in HIV-infected patients C Renou, A Lafeuillade, JF Cadranel, N Pavio, A Pariente, T Allègre, ... Aids 24 (10), 1493-1499, 2010 | 90 | 2010 |
Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure S Mohamed, G Penaranda, D Gonzalez, C Camus, H Khiri, R Boulmé, ... Aids 28 (9), 1315-1324, 2014 | 84 | 2014 |
Point-of-care versus central laboratory measurements of hemoglobin, hematocrit, glucose, bicarbonate and electrolytes: a prospective observational study in critically ill patients J Allardet-Servent, M Lebsir, C Dubroca, M Fabrigoule, S Jordana, ... PloS one 12 (1), e0169593, 2017 | 77 | 2017 |
Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients M Bourliere, G Penaranda, D Ouzan, C Renou, D Botta‐Fridlund, A Tran, ... Alimentary pharmacology & therapeutics 28 (4), 458-467, 2008 | 77 | 2008 |
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs D Ouzan, G Pénaranda, H Joly, H Khiri, A Pironti, P Halfon Journal of Clinical Virology 58 (4), 713-717, 2013 | 74 | 2013 |